Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-10

FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for atorvastatin calcium film-coated tablets from Rising Pharma Holdings, Inc., supporting a generic version of ator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM, FILM COATED)